Cell Source PEG Ratio

Cell Source posts a PEG ratio of 12.09. That is below the Healthcare sector average of 27.75. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a PEG ratio near 27.75 is typical. Cell Source's 12.09 is lower that level. That is roughly 56.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Cell Source's PEG ratio of 12.09 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for CLCS's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 27.75), and (3) consistency with growth and profitability. This page covers the first two; Cell Source's other metric pages and overview cover the third.

Judging Cell Source against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in PEG ratio easier to interpret. Start with 12.09 here, then scan peer and history charts to see if the gap is persistent.